PFIZER aquires pain drug maker KING for USD 3.6 billion.
The deal would be Pfizer's biggest since its $68 billion purchase of Wyeth last year.
King gives Pfizer access to the Fletcher pain patch and abuse resistant pain treatment "Embeda".
Pfizer said it is looking to expand its pain products beyond the arthritis treatment "Celebrex" and nerve pain treatment "Lyrica"
King had $1.78 billion in revenue last year and is focused on making pain medecations that patients can't overuse.
From Business Standard (India)
PFIZER aquires pain drug maker KING for USD 3.6 billion.The deal...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.508M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $6.592K | 2.204M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 53 | 96714175 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 19678077 | 12 |
View Market Depth
| Last trade - 15.57pm 21/06/2024 (20 minute delay) ? |
| AVE (ASX) Chart |